Ibuprofen

Description

The product is available in tablet form, with packaging options of 100 count and 50 count.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, muscular aches, minor pain of arthritis, toothache, backache, the common cold, and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are advised to take 1 tablet every 4 to 6 hours as needed while symptoms persist. In cases where pain or fever does not adequately respond to 1 tablet, a dosage of 2 tablets may be administered. It is imperative that the total daily dosage does not exceed 6 tablets within a 24-hour period, unless otherwise directed by a healthcare professional.

For children under 12 years of age, it is recommended to consult a doctor for appropriate dosing guidance.

Contraindications

Use of this product is contraindicated in patients with a history of allergic reactions to ibuprofen or any other pain reliever or fever reducer. Additionally, it should not be administered immediately before or after heart surgery due to potential complications associated with surgical recovery.

Warnings and Precautions

Ibuprofen has the potential to induce severe allergic reactions, particularly in individuals with a known allergy to aspirin. Symptoms indicative of such reactions may include hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters. In the event of an allergic reaction, it is imperative to discontinue use immediately and seek emergency medical assistance.

Healthcare professionals should be vigilant for signs of stomach bleeding in patients taking ibuprofen. Patients must be advised to stop taking the medication and contact their healthcare provider if they experience any of the following symptoms: feeling faint, vomiting blood, passing bloody or black stools, or experiencing persistent stomach pain that does not improve.

Additionally, patients should be instructed to seek medical attention if they exhibit symptoms suggestive of heart problems or stroke, which may include chest pain, difficulty breathing, unilateral weakness, slurred speech, or leg swelling.

It is also crucial to monitor the duration and severity of symptoms while on ibuprofen. Patients should discontinue use and consult their physician if pain worsens or persists beyond 10 days, if fever intensifies or lasts more than 3 days, if there is noticeable redness or swelling in the affected area, or if any new symptoms arise. Regular assessment of these parameters is essential to ensure patient safety and effective management of their condition.

Side Effects

Patients may experience a range of adverse reactions while using ibuprofen, which can vary in seriousness and frequency.

Severe allergic reactions have been reported, particularly in individuals with a known allergy to aspirin. Symptoms of such reactions may include hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters.

Patients should discontinue use and consult a healthcare professional if they experience any signs of stomach bleeding, which may manifest as feeling faint, vomiting blood, having bloody or black stools, or experiencing stomach pain that does not improve. Additionally, symptoms indicative of heart problems or stroke, such as chest pain, difficulty breathing, weakness on one side of the body, slurred speech, or leg swelling, warrant immediate medical attention.

Other important considerations include the need to stop use if pain persists for more than 10 days, if fever worsens or lasts more than 3 days, if redness or swelling occurs in the painful area, or if any new symptoms arise.

Patients with a history of stomach issues, such as heartburn, or those with conditions like high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or a history of stroke should exercise caution. The warning regarding stomach bleeding is particularly relevant for these individuals. Furthermore, patients taking diuretics or aspirin for heart attack or stroke should be aware that ibuprofen may diminish the cardioprotective effects of aspirin.

It is advised that patients under a physician's care for any serious condition or those taking other medications consult their healthcare provider regarding the use of ibuprofen to avoid potential complications or interactions.

Drug Interactions

The concomitant use of ibuprofen with aspirin may diminish the cardioprotective effects of aspirin, particularly when aspirin is utilized for the prevention of heart attack or stroke. Therefore, it is advisable to avoid the simultaneous administration of these medications to ensure optimal therapeutic outcomes.

When ibuprofen is used in conjunction with anticoagulants or corticosteroids, there is an increased risk of gastrointestinal bleeding. Clinicians should exercise caution and consider monitoring patients closely for signs of bleeding, as well as evaluating the necessity of dosage adjustments based on individual patient risk factors.

Additionally, the co-administration of ibuprofen with other nonsteroidal anti-inflammatory drugs (NSAIDs), including both prescription and over-the-counter options such as aspirin and naproxen, may further elevate the risk of gastrointestinal bleeding. It is recommended that healthcare providers assess the overall NSAID burden in patients and consider alternative pain management strategies when appropriate.

Packaging & NDC

Below are the non-prescription pack sizes of Ibuprofen. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 1 tablet every 4 to 6 hours as needed while symptoms persist. If pain or fever does not adequately respond to 1 tablet, 2 tablets may be administered. The maximum dosage should not exceed 6 tablets in a 24-hour period unless directed by a healthcare provider.

Geriatric Use

Elderly patients, particularly those aged 60 years and older, may have an increased risk of severe stomach bleeding. Healthcare providers should exercise caution when prescribing this medication to geriatric patients, considering the potential for heightened adverse effects.

It is advisable to closely monitor elderly patients for any signs of gastrointestinal bleeding and to evaluate the necessity of dosage adjustments based on individual patient factors. Careful assessment of the risk-benefit profile is essential in this population to ensure safe and effective use of the medication.

Pregnancy

Pregnant patients and women who are breastfeeding should consult a healthcare professional before using this medication. It is particularly important to avoid the use of ibuprofen during the last trimester of pregnancy unless specifically directed by a physician, as it may pose risks to the developing fetus and lead to complications during delivery. Healthcare providers should weigh the potential benefits against the risks when considering the use of ibuprofen in pregnant patients, especially in the later stages of pregnancy.

Lactation

Lactating mothers are advised to consult a health professional before using this medication while breastfeeding. It is particularly important to avoid the use of ibuprofen during the last three months of pregnancy unless specifically directed by a healthcare provider, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data provided regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering its use in lactating individuals.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient factors when treating patients with renal impairment, as the absence of detailed guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as per established protocols. Consultation with a poison control center or toxicology expert is recommended to guide further management and treatment decisions.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

It is especially important not to use ibuprofen during the last three months of pregnancy unless definitely directed to do so by a doctor, as it may cause problems in the unborn child or complications during delivery. No specific non-teratogenic effects or additional nonclinical toxicology details are available in the provided data. Furthermore, there are no specific findings related to animal pharmacology and toxicology.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions reported voluntarily or through surveillance programs. These include allergic reactions such as hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters. Severe stomach bleeding has been noted, particularly in individuals over 60 years of age, those with a history of stomach ulcers or bleeding problems, and those concurrently using blood thinners or other nonsteroidal anti-inflammatory drugs (NSAIDs).

Additionally, there is an increased risk of heart attack, heart failure, and stroke associated with NSAID use, especially when utilized in higher doses or for extended durations. Symptoms indicative of stomach bleeding, such as feeling faint, vomiting blood, having bloody or black stools, and experiencing persistent stomach pain, have also been reported.

Symptoms suggestive of heart problems or stroke, including chest pain, difficulty breathing, unilateral weakness, slurred speech, and leg swelling, have been documented. Furthermore, reports indicate instances of pain worsening or persisting beyond 10 days, fever worsening or lasting more than 3 days, and the emergence of redness or swelling in the affected area. New symptoms have also been observed during the course of treatment.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 in the event of an overdose.

Patients should be instructed to take the medication with food or milk if they experience stomach upset. It is important for healthcare providers to encourage patients to consult a doctor before using this medication if they have experienced problems or serious side effects from pain relievers or fever reducers in the past.

Providers should also emphasize the necessity of consulting a doctor if the patient has a history of stomach issues, such as heartburn, or if the stomach bleeding warning applies to them. Additionally, patients with high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or a history of stroke should be advised to seek medical advice prior to use.

Patients taking diuretics should be encouraged to discuss their medication with a healthcare provider before starting this treatment. Furthermore, it is crucial for patients who are taking aspirin for heart attack or stroke to consult a doctor or pharmacist, as ibuprofen may reduce the effectiveness of aspirin in this context.

Lastly, healthcare providers should remind patients to inform their doctor or pharmacist if they are under care for any serious condition or if they are taking any other medications, to ensure safe and effective use of the medication.

Storage and Handling

The product is supplied in a configuration that includes an NDC number for identification. It should be stored at a temperature range of 20-25°C (68-77°F), in accordance with USP Controlled Room Temperature guidelines.

It is imperative to ensure that the foil inner seal remains intact; the product should not be used if the seal is broken or missing. Proper handling and storage conditions are essential to maintain the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Ibuprofen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)